Purchase
Description
Alemtuzumab biosimilar is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) directed against the 21-28 kD cell surface glycoprotein, CD52, is an IgG1 kappa antibody with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody. The alemtuzumab biosimilar has an approximate molecular weight of 150 kD and is produced in mammalian cell (Chinese hamster ovary) suspension culture in a medium.
Alemtuzumab biosimilar is supplied at a concentration of 30 mg/mL as a sterile, preservative-free, clear, colorless, isotonic solution (pH6.8-7.4), which contains 8.0 mg/mL sodium chloride, 1.44 mg/mL dibasic sodium phosphate, 0.2 mg/mL potassium chloride, 0.2 mg/mL monobasic potassium phosphate, 0.1 mg/mL polysorbate 80, and 0.0187 mg/mL disodium edetate dihydrate. No preservatives are added.
Statement: this product is used for R&D
only, not for clinical usage.
Properties
|
Name
|
Alemtuzumab biosimilar
|
|
CAS
NO.
|
216503-57-0
|
|
Type
|
Whole
antibody
|
|
Source
|
Humanized (from rat)
|
|
Target
|
CD52
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
150 kDa
|
|
Formula
|
C6468H10066N1732O2005S40
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Place
of Origin
|
China (Mainland)
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/2018050815350233233.rar
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Alemtuzumab
|
